Good luck with your investment journey.
With the recent positive announcements from each company (RAC, IMU, CHM) and after getting "comfortable" with each company, CHM stands out as the most compelling.
* Very low MC
* Very good results that are streamlined to treating SPECIFIC cancers
* Small team
* I feel Jen Chow has really proven herself as a mover and shaker. I feel that the last acquisition from IMU was mostly due to her.
I for one really believe out of IMU, RAC and CHM, that CHM is the superior investment.
- Forums
- ASX - By Stock
- CHM
- Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
CHM
chimeric therapeutics limited
Add to My Watchlist
25.0%
!
0.3¢

Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial, page-37
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $9.747M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $11.33K | 3.775M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
75 | 71644408 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 87927011 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
75 | 71644408 | 0.003 |
30 | 29940488 | 0.002 |
13 | 53914001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 87927011 | 26 |
0.005 | 34943562 | 24 |
0.006 | 17929018 | 21 |
0.007 | 6512518 | 7 |
0.008 | 7317101 | 5 |
Last trade - 14.48pm 31/07/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |